Clinical Trial Update: Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating dupilumab for alopecia areata in patients with and without atopic dermatitis; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2022-02-14